281 related articles for article (PubMed ID: 18925842)
1. Papillary thyroid carcinoma tall cell variant.
Ghossein R; Livolsi VA
Thyroid; 2008 Nov; 18(11):1179-81. PubMed ID: 18925842
[TBL] [Abstract][Full Text] [Related]
2. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.
Ghossein RA; Leboeuf R; Patel KN; Rivera M; Katabi N; Carlson DL; Tallini G; Shaha A; Singh B; Tuttle RM
Thyroid; 2007 Jul; 17(7):655-61. PubMed ID: 17696836
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of papillary thyroid carcinoma with tall-cell features.
Ganly I; Ibrahimpasic T; Rivera M; Nixon I; Palmer F; Patel SG; Tuttle RM; Shah JP; Ghossein R
Thyroid; 2014 Apr; 24(4):662-70. PubMed ID: 24262069
[TBL] [Abstract][Full Text] [Related]
4. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
[TBL] [Abstract][Full Text] [Related]
5. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma.
Lee SH; Jung CK; Bae JS; Jung SL; Choi YJ; Kang CS
Diagn Cytopathol; 2014 Jan; 42(1):11-7. PubMed ID: 23754825
[TBL] [Abstract][Full Text] [Related]
6. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens.
Solomon A; Gupta PK; LiVolsi VA; Baloch ZW
Diagn Cytopathol; 2002 Sep; 27(3):143-8. PubMed ID: 12203860
[TBL] [Abstract][Full Text] [Related]
9. Age of patients with papillary thyroid carcinoma: is it a key factor in the development of variants?
Das DK
Gerontology; 2005; 51(3):149-54. PubMed ID: 15832039
[TBL] [Abstract][Full Text] [Related]
10. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
11. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.
Morris LG; Shaha AR; Tuttle RM; Sikora AG; Ganly I
Thyroid; 2010 Feb; 20(2):153-8. PubMed ID: 20151822
[TBL] [Abstract][Full Text] [Related]
12. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.
Liu Z; Zeng W; Chen T; Guo Y; Zhang C; Liu C; Huang T
Oncotarget; 2017 Jan; 8(4):6222-6232. PubMed ID: 28009980
[TBL] [Abstract][Full Text] [Related]
14. Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?
Hernandez-Prera JC; Machado RA; Asa SL; Baloch Z; Faquin WC; Ghossein R; LiVolsi VA; Lloyd RV; Mete O; Nikiforov YE; Seethala RR; Suster S; Thompson LD; Turk AT; Sadow PM; Urken ML; Wenig BM
Thyroid; 2017 Dec; 27(12):1498-1504. PubMed ID: 29020884
[TBL] [Abstract][Full Text] [Related]
15. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
[TBL] [Abstract][Full Text] [Related]
16. Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age.
Villar-Taibo R; Peteiro-González D; Cabezas-Agrícola JM; Aliyev E; Barreiro-Morandeira F; Ruiz-Ponte C; Cameselle-Teijeiro JM
Oncol Lett; 2017 May; 13(5):3501-3507. PubMed ID: 28529577
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features and molecular characteristics of tall cell and hobnail variants of papillary thyroid carcinoma].
Zhang M; Duan HL; Wang LM; Gao W; Yao YY; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1234-1239. PubMed ID: 34719160
[No Abstract] [Full Text] [Related]
18. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma.
Leung AK; Chow SM; Law SC
Laryngoscope; 2008 Jan; 118(1):32-8. PubMed ID: 18025951
[TBL] [Abstract][Full Text] [Related]
19. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
20. Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
Wong KS; Higgins SE; Marqusee E; Nehs MA; Angell T; Barletta JA
Endocr Pathol; 2019 Mar; 30(1):43-48. PubMed ID: 30565013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
